NewslettersCell Therapy News Quantification of Circulating TCR-Engineered T Cells Targeting a Human Endogenous Retrovirus Post-Adoptive Transfer Using Nanoplate Digital PCR By lbeveridge - August 26, 2024 0 71 Investigators developed and evaluated the feasibility and performance of nanoplate-based digital PCR to quantify adoptively infused T cells engineered with a TCR that recognizes a HERV-E antigen. [Molecular Therapy-Methods & Clinical Development] Abstract